You are here

  • Home
  • Archive
  • Volume 70, Issue 1
  • High CCL27 immunoreactivity in ‘supratumoral’ epidermis correlates with better prognosis in patients with cutaneous malignant melanoma

Article info

Article menu
Download PDFPDF
Original article
High CCL27 immunoreactivity in ‘supratumoral’ epidermis correlates with better prognosis in patients with cutaneous malignant melanoma

Authors

  • Miguel Martinez-Rodriguez Department of Pathology, Hospital Clínico Universitario-INCLIVA, University of Valencia, Valencia, Spain Department of Pathology, Telemark Hospital, Skien, Norway PubMed articlesGoogle scholar articles
  • Alec K Thompson Department of Dermatopathology and Ocular Pathology, Ullevål University Hospital, University of Oslo Medical Center, Oslo, Norway PubMed articlesGoogle scholar articles
  • Carlos Monteagudo Department of Pathology, Hospital Clínico Universitario-INCLIVA, University of Valencia, Valencia, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Miguel Martinez-Rodriguez, Department of Pathology, Telemark Hospital, Ulefossveien 55, Skien 3710, Norway; mimarro111{at}hotmail.com
View Full Text

Citation

Martinez-Rodriguez M, Thompson AK, Monteagudo C
High CCL27 immunoreactivity in ‘supratumoral’ epidermis correlates with better prognosis in patients with cutaneous malignant melanoma
Journal of Clinical Pathology 2017;70:15-19.

Publication history

  • Received November 30, 2015
  • Revised April 12, 2016
  • Accepted April 30, 2016
  • First published June 20, 2016.
Online issue publication 
June 14, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/